Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Authors
Keywords
-
Journal
NATURE REVIEWS MICROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-03
DOI
10.1038/s41579-019-0249-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein-Barr virus microRNAs regulate B cell receptor signal transduction and lytic reactivation
- (2019) Yan Chen et al. PLoS Pathogens
- Defective Epstein–Barr virus in chronic active infection and haematological malignancy
- (2019) Yusuke Okuno et al. Nature Microbiology
- EBV miRNA expression profiles in different infection stages: A prospective cohort study
- (2019) Anita Hartung et al. PLoS One
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas
- (2019) Julia Rühl et al. JOURNAL OF CLINICAL INVESTIGATION
- Infection and immune control of human oncogenic γ-herpesviruses in humanized mice
- (2019) Donal McHugh et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors
- (2019) Andrea Walens et al. eLife
- Understanding the immunology of the Zostavax shingles vaccine
- (2019) Nicole L Sullivan et al. CURRENT OPINION IN IMMUNOLOGY
- Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
- (2018) James P. Dugan et al. CLINICAL CANCER RESEARCH
- An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
- (2018) Joost Snijder et al. IMMUNITY
- Lymphomas driven by Epstein–Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
- (2018) Sana AlQarni et al. ONCOGENE
- EBV persistence without its EBNA3A and 3C oncogenes in vivo
- (2018) Anita Murer et al. PLoS Pathogens
- Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
- (2018) Agnieszka Szymula et al. PLoS Pathogens
- Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
- (2018) Jia Chen et al. Nature Microbiology
- Epstein–Barr Virus and Cancer
- (2018) Paul J. Farrell Annual Review of Pathology-Mechanisms of Disease
- An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model
- (2018) James C. Romero-Masters et al. PLoS Pathogens
- A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
- (2018) Jillian A. Bristol et al. PLoS Pathogens
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis
- (2017) Brigid Chiyoko Poling et al. VIROLOGY
- Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
- (2017) Andrea Bilger et al. Oncotarget
- A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells
- (2017) Ina Ersing et al. Cell Reports
- EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
- (2017) Christine T. Styles et al. PLOS BIOLOGY
- The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus
- (2017) Jinlin Li et al. PLoS Pathogens
- Peer review is not broken
- (2017) Nature Microbiology
- The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases
- (2016) J. A. Kanakry et al. BLOOD
- Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency
- (2016) Coral K. Wille et al. JOURNAL OF VIROLOGY
- The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells
- (2016) Lindsey M. Hutt-Fletcher JOURNAL OF VIROLOGY
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
- (2016) Manuel Albanese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BDLF3 gene product of Epstein-Barr virus , gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection
- (2016) Liudmila S. Chesnokova et al. VIROLOGY
- Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?
- (2016) Jennifer Totonchy et al. Current Opinion in Virology
- A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog
- (2016) Katharina Bernhardt et al. PLoS Pathogens
- Epstein-Barr Virus: The Path from Latent to Productive Infection
- (2016) Ya-Fang Chiu et al. Annual Review of Virology
- The Immunology of Epstein-Barr Virus–Induced Disease
- (2015) Graham S. Taylor et al. Annual Review of Immunology
- The tumor virus landscape of AIDS-related lymphomas
- (2015) A. Arvey et al. BLOOD
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice
- (2015) Goran Gregorovic et al. JOURNAL OF VIROLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch
- (2015) Coral K. Wille et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
- (2015) Alexander M. Price et al. PLoS Pathogens
- The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events
- (2015) Samantha K. Dunmire et al. PLoS Pathogens
- Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
- (2015) Raymond Wai-Ming Lung et al. NEOPLASIA
- MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
- (2014) Y.-J. Jung et al. JOURNAL OF VIROLOGY
- Cellular Differentiation Regulator BLIMP1 Induces Epstein-Barr Virus Lytic Reactivation in Epithelial and B Cells by Activating Transcription from both the R and Z Promoters
- (2014) Jessica A. Reusch et al. JOURNAL OF VIROLOGY
- Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma
- (2014) Satoko Morishima et al. LEUKEMIA & LYMPHOMA
- A Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
- (2014) Charles Torgbor et al. PLoS Pathogens
- Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
- (2014) Olga Antsiferova et al. PLoS Pathogens
- Gammaherpesviruses and Lymphoproliferative Disorders
- (2013) Ethel Cesarman Annual Review of Pathology-Mechanisms of Disease
- A Cluster of Virus-Encoded MicroRNAs Accelerates Acute Systemic Epstein-Barr Virus Infection but Does Not Significantly Enhance Virus-Induced Oncogenesis In Vivo
- (2013) A. Wahl et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Transcytosis through Polarized Oral Epithelial Cells
- (2013) S. M. Tugizov et al. JOURNAL OF VIROLOGY
- Evolutionary Conservation of Primate Lymphocryptovirus MicroRNA Targets
- (2013) R. L. Skalsky et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus maintains lymphomas via its miRNAs
- (2013) D T Vereide et al. ONCOGENE
- Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
- (2013) Ming-Han Tsai et al. Cell Reports
- Induction of p16INK4a Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
- (2013) Lenka Skalska et al. PLoS Pathogens
- EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1
- (2013) Eva Klein et al. OncoImmunology
- Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
- (2012) C. Smith et al. CANCER RESEARCH
- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
- (2012) Baochun Zhang et al. CELL
- EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency
- (2012) Kasandra J Riley et al. EMBO JOURNAL
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
- (2012) Robert E. White et al. JOURNAL OF CLINICAL INVESTIGATION
- Lytic Epstein-Barr virus infection in epithelial cells but not in B-lymphocytes is dependent on Blimp1
- (2012) M. Buettner et al. JOURNAL OF GENERAL VIROLOGY
- Shutoff of BZLF1 Gene Expression Is Necessary for Immortalization of Primary B Cells by Epstein-Barr Virus
- (2012) X. Yu et al. JOURNAL OF VIROLOGY
- Analysis of Epstein-Barr Virus-Regulated Host Gene Expression Changes through Primary B-Cell Outgrowth Reveals Delayed Kinetics of Latent Membrane Protein 1-Mediated NF- B Activation
- (2012) A. M. Price et al. JOURNAL OF VIROLOGY
- Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
- (2012) C. K. Wille et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
- (2012) S.-D. Ma et al. JOURNAL OF VIROLOGY
- BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
- (2012) Kostas Paschos et al. NUCLEIC ACIDS RESEARCH
- BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
- (2012) Anne Woellmer et al. PLoS Pathogens
- The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
- (2012) Rebecca L. Skalsky et al. PLoS Pathogens
- Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
- (2011) R. Suzuki et al. BLOOD
- Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation
- (2011) S. Ruf et al. JOURNAL OF CLINICAL VIROLOGY
- The Members of an Epstein-Barr Virus MicroRNA Cluster Cooperate To Transform B Lymphocytes
- (2011) R. Feederle et al. JOURNAL OF VIROLOGY
- Cellular Gene Expression That Correlates with EBER Expression in Epstein-Barr Virus-Infected Lymphoblastoid Cell Lines
- (2011) G. Gregorovic et al. JOURNAL OF VIROLOGY
- cis-Acting Effects on RNA Processing and Drosha Cleavage Prevent Epstein-Barr Virus Latency III BHRF1 Expression
- (2011) L. Xing et al. JOURNAL OF VIROLOGY
- Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4Aand p14ARFexpression
- (2011) Seiji Maruo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus
- (2011) Regina Feederle et al. PLoS Pathogens
- An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells
- (2010) Pavel A. Nikitin et al. Cell Host & Microbe
- Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation
- (2010) R. Amoroso et al. JOURNAL OF VIROLOGY
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
- (2010) S.-D. Ma et al. JOURNAL OF VIROLOGY
- Infectious Mononucleosis
- (2010) Katherine Luzuriaga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphoid Hyperplasia and Lymphoma in Transgenic Mice Expressing the Small Non-Coding RNA, EBER1 of Epstein-Barr Virus
- (2010) Claire E. Repellin et al. PLoS One
- HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
- (2010) H. Hjalgrim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells
- (2010) Eri Seto et al. PLoS Pathogens
- Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency
- (2009) C. McDonald et al. JOURNAL OF GENERAL VIROLOGY
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
- (2009) Marie L. Hertle et al. PLoS Pathogens
- EBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
- (2008) T. Xia et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More